AlphAIalphai — Financial news for AI agents
SEC EDGARSEP 41 min read$ALEC

Berkley Neil Lindsay sold $78K of ALEC

Berkley Neil Lindsay (CFO & Chief Business Officer) sold 29,251 shares of Alector, Inc. (ALEC) at $2.66 on 2026-09-03.

Original reporting
SEC EDGAR · Berkley Neil Lindsay
Published Sep 4, 2026, 9:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 9:47 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ALEC
Neutral
high confidence
Mentioned
$ALEC
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALECNeutralLow
01

Why it matters

The CFO's sale is modest and does not alter control or strategic direction.

02

Market read

Insider sale is routine; limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed in this filing.

Relevance 3/10Novelty 4/10Timing: post-market 2026-09-03

Background

Form 4 filings disclose insider transactions; investors monitor them for signals.

Company-level read

Ticker impact

$ALECNeutralHigh confidence
Context

CFO Berkley Neil Lindsay sold 29,251 shares for $77,948, reducing his stake to 350,649 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale amount is small relative to market cap and typical insider trading volumes.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

The sale could signal insider concern, but size is too small to be meaningful.

Key entities

  • Company
    Alector, Inc.

    Biotech firm developing neurodegenerative disease therapies.

  • Individual
    Berkley Neil Lindsay

    Chief Financial Officer and Chief Business Officer of Alector.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ALEC insider trading history →

Related articles

AUG 6
$ALECMed

Alector, Inc. (ALEC): Results of Operations and Financial Condition

Alector, Inc. (ALEC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Alector Reports Second Quarter 2026 Financial Results and Provides Business Update Advancing the Alector Brain Carrier (ABC) blood-brain barrier platform across antibodies, enzymes, and siRNA, with AL137 advancing as Alector’s lead ABC-enabled anti-amyloid beta (Aβ)

SEC EDGAR 8-K6 min
JUN 8
$ALECMedAI 8/10

UAE Business: ALEC unit Target wins $500m three EPC contracts in Gulf

ALEC Holdings said its subsidiary Target Engineering Construction Company – SP won three Gulf EPC contracts totaling over $500 million, according to a filing to the Dubai Stock Market. The projects have execution periods of 10, 21 and 36 months. ALEC said the awards’ financial impact will be recognized over those periods under its revenue policy, and it did not name clients, locations or scope.

gdnonline.com3 min